Commentary: Optimal left ventricular assist device duration in bridge to transplantation: Do we have a choice now, or is it a moot point?Central Message
Main Authors: | Sandeep Sainathan, MD, Tomas A. Salerno, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | JTCVS Open |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2666273621003855 |
Similar Items
-
Commentary: Surgical ventricular reconstruction is the right choiceCentral Message
by: Lorenzo Arturo Menicanti, MD
Published: (2021-09-01) -
The good, the bad, the ugly: Optimal left ventricular assist device duration in bridge to transplantationCentral Message
by: Matthew L. Goodwin, MD, et al.
Published: (2021-12-01) -
Commentary: Okay, now what?Central Message
by: Charles B. Huddleston, MD, et al.
Published: (2021-06-01) -
Commentary: Left ventricular assist device infection: Welcome to Babel!Central Message
by: Michele Di Mauro, MD, PhD, MSc Biostat, et al.
Published: (2021-12-01) -
Commentary: Ventricular recovery with left ventricular assist device support: The failed quest for the Holy Grail?Central Message
by: Nader Moazami, MD, et al.
Published: (2021-12-01)